PATENT CLAIM ANALYSIS

Application Number: 15746182
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["544", "008000"]

Abstract:
The invention provides a series of chlorobenzene substituted azaaryl compounds having activity in inhibiting cancer cell growth and low toxicity to normal cells. Particularly, the compounds of the invention have stronger inhibition effect on bladder cancer and liver cancer.

Claim (Index 2):
The compound of  claim 1 , wherein halo is F, Cl or Br; alkyl is C1-10alkyl, preferably C1-6alkyl or C1-4alkyl; alkenyl is C2-10alkenyl, preferably C2-6alkenyl; alkynyl is C2-10alkynyl, preferably C2-6alkynyl; alkoxy is C1-10alkoxy, preferably C1-6alkoxy or C1-4alkoxy; aryl is 5- or 6-membered aryl, preferably phenyl; and heterozryl is 5- or 6-membered heteroaryl and has 1 to 3 heteroatoms selected from the group consisting of N, O and S.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.23529
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15230700', '13391148', '11570966', '13575799', '15181903']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7661859217749063
- 35 USC 102 Novelty (BERT): 0.5146850763886092
- Combined Prediction Score: 0.7410358372362766
- Mean Citation Score: 260.94092800000004
- Max Citation Score: 291.13596
- Similarity Product: 202.6193254902577

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test